Effects of lovastatin in diabetic patients treated with chlorpropamide.

Author: AllanJ, JohnsonB F, LaBelleP, RoncaP D, WilsonJ, ZupkisR V

Paper Details 
Original Abstract of the Article :
Patients with non-insulin dependent diabetes mellitus (NIDDM) have a higher risk of atherosclerotic cardiovascular disease than nondiabetic subjects. In seven patients with both hypercholesterolemia and NIDDM controlled by chlorpropamide, lovastatin (20 mg b.i.d. for 6 weeks) lowered low-density lip...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1038/clpt.1990.176

データ提供:米国国立医学図書館(NLM)

Lovastatin and Diabetic Control: A Promising Combination

This research explores the potential of lovastatin, a cholesterol-lowering drug, to manage hypercholesterolemia in patients with non-insulin-dependent diabetes mellitus (NIDDM). The study, similar to a desert traveler seeking a safe and effective route through the sands, investigates the safety and efficacy of lovastatin in this specific patient population. The authors aimed to determine whether lovastatin could effectively lower cholesterol levels without compromising diabetic control or interacting negatively with the existing medication, chlorpropamide.

Balancing Cholesterol and Diabetes

The research reveals that lovastatin effectively lowers cholesterol levels in patients with NIDDM without negatively impacting blood sugar control or interacting with chlorpropamide. This finding is similar to a desert traveler finding a path that avoids treacherous sand dunes while still reaching their destination. The study suggests that lovastatin can be a valuable addition to the treatment regimen for patients with both hypercholesterolemia and NIDDM, offering a safer and more effective approach to managing both conditions simultaneously.

Managing Cholesterol and Diabetes

This research provides evidence supporting the use of lovastatin for managing cholesterol levels in patients with NIDDM. It's like having a guide through the desert, ensuring a safe and effective journey toward better health. The study suggests that lovastatin can be a valuable tool for improving the overall health and well-being of these patients, allowing them to navigate the challenges of their condition with greater confidence.

Dr. Camel's Conclusion

This research provides valuable insights into the management of hypercholesterolemia in patients with NIDDM. It's like finding a hidden oasis in the desert, offering a safe and effective way to navigate the challenges of both conditions. The study suggests that lovastatin, when used judiciously, can be a valuable tool for improving the overall health and well-being of these patients.
Date :
  1. Date Completed 1990-12-10
  2. Date Revised 2019-05-10
Further Info :

Pubmed ID

2225707

DOI: Digital Object Identifier

10.1038/clpt.1990.176

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.